Subscribe to Newsletter

Discovery & Development

Discovery & Development Drug Delivery

At First Sight

| Jamie Irvine | 13 min read

Three companies – Cardinal Health, REGENXBIO, and Beacon Therapeutics – help us explore gene therapy development in the ophthalmic space

Discovery & Development Clinical Trials

Clinical Trials 4.0

| 4 min read

Clinical trials are ripe for improvement; here’s how centralized study information can help

Discovery & Development Drug Discovery

Humans and Machines: Exploring the Reaches of Chemical Space

| Ryan Walsh, Ying Zhang | 6 min read

Machine learning has significant promise, but we should never overlook the importance of the human factor.

Discovery & Development Drug Delivery

MIA and Potent Plants

| Jamie Irvine | 2 min read

Can genetically engineering yeast be used to produce safe and scalable schizophrenia plant-inspired drugs?

Discovery & Development Drug Delivery

Bringing a New MOA to the Table

| Jamie Irvine | 3 min read

Cerevel Therapeutics' Emraclidine - in development for schizophrenia and Alzheimer’s disease psychosis - yields positive results in phase Ib trial

Discovery & Development Drug Delivery

Artificial Future

| Jamie Irvine | 3 min read

Exploring the potential of hybrid peptide-DNA nanostructures and artificial life

Discovery & Development Drug Discovery

A New Model of Drug Discovery

| Jamie Irvine | 2 min read

How multi-omics and AI-driven target identification can drive the future of personalized medicine

Discovery & Development Drug Delivery

One Vaccine to Rule Them All

| Jamie Irvine | 2 min read

A superbug vaccine could protect patients against multiple healthcare-associated infections at once

Discovery & Development Clinical Trials

Clinical Trials: How Far We’ve Come

| Claude Price | 6 min read

Clinical trials have improved greatly over the years, but there is still much to be done.

Discovery & Development Drug Discovery

Minds, Interrupted

| Ashlea Segal, Alex Fornito | 2 min read

Researchers develop a new approach to mapping the individual heterogeneity of brain changes in mental disorders

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register